S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q4 2020

Avoro Capital Advisors

Period: Q4 2020 Β· Filed: 2021-02-16
View on SEC EDGAR β†—
AUM
$5.81B
Total portfolio value
Positions
44
Reported securities
Top Holding
MRTX
17.1% $996.1M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-02-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MRTXMIRATI THERAPEUTICS INC$996.1M17.15%β€”β€”
17.1%
HZNPHORIZON THERAPEUTICS PLC$658.4M11.34%β€”β€”
11.3%
UTHRUNITED THERAPEUTICS CORP$432.6M7.45%$151.79$555.91+266.2%
7.5%
IOVAIOVANCE BIOTHERAPEUTICS INC$348.0M5.99%$46.40$4.31-90.7%
6.0%
ARNAARENA PHARMACEUTICALS INC$321.9M5.54%β€”β€”
5.5%
ASNDASCENDIS PHARMA$300.2M5.17%$166.78$274.50+64.6%
5.2%
SRPTSAREPTA THERAPEUTICS INC$298.4M5.14%$170.49$19.28-88.7%
5.1%
ARGXARGENX SE$265.4M4.57%$294.09$939.68+219.5%
4.6%
FOLDAMICUS THERAPEUTICS INC$207.8M3.58%β€”β€”
3.6%
XLRNACCELERON PHARMA INC$198.3M3.42%β€”β€”
3.4%
MRSNMERSANA THERAPEUTICS INC$180.9M3.12%β€”β€”
3.1%
BMRNBIOMARIN PHARMACEUTICAL INC$144.7M2.49%$87.69$58.99-32.7%
2.5%
MDGLMADRIGAL PHARMACEUTICALS INC$136.2M2.35%$111.17$528.10+375.0%
2.4%
KURAKURA ONCOLOGY INC$130.6M2.25%$32.66$11.10-66.0%
2.3%
PMVPPMV PHARMACEUTICALS INC$130.5M2.25%$61.51$1.22-98.0%
2.3%
ACADACADIA PHARMACEUTICALS INC$104.3M1.80%$53.46$25.97-51.4%
1.8%
ADVMADVERUM BIOTECHNOLOGIES INC$86.7M1.49%β€”β€”
1.5%
TRILLIUM THERAPEUTICS INC$85.3M1.47%β€”β€”
1.5%
CNSTCONSTELLATION PHARMACEUTICALS INC$85.0M1.46%β€”β€”
1.5%
DCPHDECIPHERA PHARMACEUTICALS INC$74.2M1.28%β€”β€”
1.3%
PRAXPRAXIS PRECISION MEDICINES INC$68.7M1.18%$825.30$318.52-61.4%
1.2%
CBAYCYMABAY THERAPEUTICS INC$59.1M1.02%β€”β€”
1.0%
ISEEIVERIC BIO INC$50.1M0.86%β€”β€”
0.9%
TVTXTRAVERE THERAPEUTICS INC$49.1M0.85%$27.25$56.92+108.9%
0.8%
RLMDRELMADA THERAPEUTICS INC$48.9M0.84%$32.07$6.28-80.4%
0.8%
XENEXENON PHARMACEUTICALS INC$43.1M0.74%$15.38$60.96+296.4%
0.7%
MRNSMARINUS PHARMACEUTICALS INC$39.4M0.68%β€”β€”
0.7%
OLMAOLEMA PHARMACEUTICALS INC$35.6M0.61%$48.08$12.64-73.7%
0.6%
AMRNXXXXAMARIN CORP PLC$29.3M0.51%β€”β€”
0.5%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$29.2M0.50%β€”β€”
0.5%

Quarter-on-Quarter Activity

Q4 2020 vs. Q3 2020

New Positions (8)

TickerIssuerNotionalSince Filing
UTHRUNITED THERAPEUTICS CORP$432.6M+266.2%
ACADACADIA PHARMACEUTICALS INC$104.3M-51.4%
PRAXPRAXIS PRECISION MEDICINES INC$68.7M-61.4%
TVTXTRAVERE THERAPEUTICS INC$49.1M+108.9%
MRNSMARINUS PHARMACEUTICALS INC$39.4M
OLMAOLEMA PHARMACEUTICALS INC$35.6M-73.7%
MNKDMANNKIND CORP$11.0M
SNDXSYNDAX PHARMACEUTICALS INC$10.0M

Exited Positions (8)

TickerIssuerNotional
IMMUIMMUNOMEDICS INC$2.23B
MYOKMYOKARDIA INC$257.0M
KPTIXXXXKARYOPHARM THERAPEUTICS INC$87.6M
QUREUNIQURE NV$64.5M
MRNSMARINUS PHARMACEUTICALS INC$38.5M
ALTALTIMMUNE INC$26.4M
RTRXRETROPHIN INC$24.5M
RAPTRAPT THERAPEUTICS INC$18.5M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
KURAKURA ONCOLOGY INC$56.0M+64.3%-66.0%
MDGLMADRIGAL PHARMACEUTICALS INC$30.5M+37.6%+375.0%
ARNAARENA PHARMACEUTICALS INC$90.1M+35.2%
PMVPPMV PHARMACEUTICALS INC$73.0M+27.0%-98.0%
HZNPHORIZON THERAPEUTICS PLC$64.1M+17.6%
XLRNACCELERON PHARMA INC$46.4M+14.8%
BDTXBLACK DIAMOND THERAPEUTICS INC$2.3M+6.2%
TRILLIUM THERAPEUTICS INC$7.2M+5.5%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ATNXATHENEX INC$-35.4M-88.6%
CUECUE BIOPHARMA INC$-22.5M-75.8%
ADAPYADAPTIMMUNE THERAPEUTICS PLC$-68.6M-67.7%
CNSTCONSTELLATION PHARMACEUTICALS INC$-1.6M-31.0%
DCPHDECIPHERA PHARMACEUTICALS INC$-19.2M-28.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$34.1M-21.4%-90.7%
FOLDAMICUS THERAPEUTICS INC$54.6M-17.1%
BMRNBIOMARIN PHARMACEUTICAL INC$11.6M-5.7%-32.7%
← Back to Hedge Funds